Working to Eradicate Gynecologic Cancers

David Corcoran, PhD

PhD
Duke Institute for Genome Sciences and Policy
101 Science Dr, CIEMAS 2171
Durham, NC
USA 27708

Papers:
289 - Poster Session A Use of SRC pathway activation in predicting dasatinib activity in ovarian cancer